Skip to Content


Treatment for Pain

ALZA Corporation Receives Approvable Letter Regarding IONSYS, an Iontophoretic, Fentanyl-containing, Transdermal Analgesic

MOUNTAIN VIEW, Calif., July 27, 2004 -- ALZA Corporation today announced it has received an approvable letter from the U.S. Food and Drug Administration (FDA) regarding a New Drug Application (NDA) for IONSYS.

ALZA submitted a NDA for IONSYS in September 2003. It is working with the FDA to address the agency's letter as quickly as possible.

ALZA Corporation, a member of the Johnson & Johnson family of companies, is a leading developer of drug delivery-based pharmaceutical products.

Posted: July 2004

Related Articles

Ionsys (fentanyl) FDA Approval History